Methadone and Thiopropazate: Interaction Details

Brand names
Methadone
DolophineDisketsWestadone +1 more
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Methadone

Brand names
  • Dolophine
  • Diskets
  • Westadone
  • Methadose Sugar-free

Thiopropazate

We don't have a drug information page for Thiopropazate yet. Have a question about Thiopropazate? Ask a pharmacist, free →

What Happens When You Take Methadone With Thiopropazate

What can happen when they are taken together (rated Major)

Increased risk of respiratory and

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

If methadone must be given together with depressants, the lowest effective dose should be used for the shortest possible time, and the patient should be watched for and .4 Denying patients access to medication-assisted treatment (MAT) can increase the morbidity and mortality associated with use disorder, even though serious adverse effects can occur.

Stopping the CNS depressant is the preferred approach. When the combination cannot be avoided, it should be monitored and managed with care.

The CNS depressant should be tapered to the lowest effective dose, or other options for treating anxiety or insomnia should be used. A Swedish epidemiological study found that patients on methadone-based or buprenorphine-based MAT who also took or other CNS depressants had a higher risk of death.

In an analysis of aggregate nationwide death certificate data from 2010 to 2014, most overdose deaths involving buprenorphine or methadone also involved of a CNS depressant.3 When concurrent use is justified, prescribing naloxone for emergency treatment of opioid overdose should be strongly considered.2

The Methadone and Thiopropazate Interaction, Explained

Taking methadone with thiopropazate can make you much sleepier and slow your breathing. Methadone is an , and thiopropazate is a phenothiazine-type medicine that also calms the brain. Together, their sedating effects add up. This can cause heavy drowsiness, dizziness, slowed or shallow breathing, and in serious cases an overdose.

Please don't stop either medicine on your own. Methadone treatment for opioid use disorder is important, and your care team can manage this with the lowest effective doses, close checks for sleepiness and breathing, and possibly a naloxone rescue kit. Ask your pharmacist or doctor about it.

and between methadone (mu-opioid ) and thiopropazate (phenothiazine with sedative properties). This is a interaction; the effect is increased and respiratory depression. Onset is unspecified. Evidence is established, and epidemiologic and death certificate data link CNS depressants with methadone-involved overdose deaths.

  • Reserve combined use for patients in whom alternatives are inadequate; use the lowest doses and shortest duration.
  • Monitor closely for sedation and respiratory depression.
  • Discontinuing the CNS depressant is preferred; otherwise consider tapering to the lowest effective dose or using alternatives for anxiety or insomnia.
  • Do not deny MAT because of concomitant CNS depressants.
  • Strongly consider prescribing naloxone.

See the 4 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Methadone and Thiopropazate Interact

The likely mechanism

In short: Methadone and thiopropazate both slow brain activity, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Methadone and Thiopropazate Interaction

Your care team can manage this combination carefully. Keep taking both medicines as prescribed unless told otherwise, and do not stop methadone on your own.

  • Your team may use the lowest doses for the shortest time needed, and the thiopropazate dose may be lowered or an alternative considered.
  • You may be monitored more closely for sleepiness and slowed breathing.
  • Ask whether you should have naloxone (an emergency overdose rescue medicine) at home, and make sure family know how to use it.
  • Avoid alcohol and other sedating medicines unless your team approves.
  • Get urgent help for extreme drowsiness, trouble waking, or slow or shallow breathing.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Methadone or Thiopropazate need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

5 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Drug Safety Communications: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

    A Swedish epidemiological study reported that patients receiving methadone- or buprenorphine-based medication-assisted treatment (MAT) together with or other depressants (eg, drugs used to treat insomnia) face a higher risk of death. For the period from July 1, 2005 to December 31, 2012, investigators analyzed the risk of fatal overdose, non-overdose related mortality, and all-cause mortality in MAT patients (aged 18 to 50), comparing periods with prescribed CNS depressants against periods without CNS depressant therapy.

    An elevated risk of all-cause mortality (adjusted hazard ratio (HR) 1.44; 95% CI, 0.93 to 2.23) and non-overdose related mortality (HR 1.74; 95% CI 1.00 to 3.01) was found with MAT plus benzodiazepine treatment; however, these data were not considered statistically significant. Results also showed an elevated risk of fatal overdose, non-overdose mortality, and all-cause mortality when MAT was coadministered with non-benzodiazepines, but only the fatal overdose and all-cause mortality findings were considered statistically significant; HR 2.34 (95% CI, 1.37 to 3.99) and HR 1.33 (95% CI, 1.12 to 2.45), respectively. The benzodiazepine and non-benzodiazepine cohorts were not compared with each other, because the authors did not adjust for the indication for which the drugs were used.3

  2. Report 2 · Study title

    Drug Safety Communications: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

    A study of aggregate nationwide death certificate data from 2010 to 2014 identified 3495 reported drug overdose deaths in 2014. Methadone and other depressants were often named as contributors to these deaths.

    Concurrent ALPRAZolam use was reported in 18.1% of cases, followed by oxyCODONE (10.1%), cocaine (9.6%), heroin (9%), and diazePAM (6.6%). The FDA reported 322 drug overdose deaths involving buprenorphine in 2014.

    Among these 322 deaths, 32.9% involved ALPRAZolam, 17.4% involved clonazePAM, 11.2% involved diazePAM, 11.2% involved heroin, and 9.9% involved fentaNYL. The absolute number of deaths involving methadone was 10 times that involving buprenorphine, although confounding factors and differences in drug utilization were not taken into account. Whether the risk of overdose death with CNS depressant drugs differed between buprenorphine and methadone is unknown.3

  3. Report 3 · Study title

    Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning

    In one study, the rate of nonmedical use-related emergency department visits involving analgesics and between 2004 and 2011 rose significantly from 11 to 34.2 per 100,000. Drug overdose deaths resulting from prescribed doses and from greater than prescribed doses of both drug classes also rose significantly, from 0.6 to 1.7 per 100,000, and the proportion of overdose deaths attributable to benzodiazepines increased significantly from 18% to 31%.1

  4. Report 4 · Study title

    Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning

    In a prospective cohort study, the rate of overdose deaths with dispensing of both analgesics and was 10 times higher than with dispensing of opioid analgesics alone (7 vs 0.7 per 10,000 person years).1

  5. Report 5 · Study title

    Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning

    In a cohort study using data from 2004 to 2009, patients taking analgesics who had a history of a prescription had a significant 2.33 fold increase in the risk of fatal overdose, and those with a current benzodiazepine prescription had a 3.86 fold increase, compared with patients taking opioid analgesics without a history of a benzodiazepine prescription. The risk of drug overdose death rose as the daily benzodiazepine dose increased.1

Methadone and Thiopropazate: Common Questions

How serious is the Methadone and Thiopropazate interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Methadone and Thiopropazate interaction managed?

Your care team can manage this combination carefully. Keep taking both medicines as prescribed unless told otherwise, and do not stop methadone on your own. Your team may use the lowest doses for the shortest time needed, and the thiopropazate dose may be lowered or an alternative considered. You may be monitored more closely for sleepiness and slowed breathing. Ask whether you should have naloxon… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Methadone with Thiopropazate?

Your team may use the lowest doses for the shortest time needed, and the thiopropazate dose may be lowered or an alternative considered.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Methadone and Thiopropazate Interaction

Ask in your own words about taking Methadone and Thiopropazate together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (4)

  1. US Food and Drug Administration (FDA): Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. US Food and Drug Administration (FDA). Silver Spring, MD. 2016.
  2. Product Information: DISKETS dispersible tablets, methadone HCl dispersible tablets. Hikma Pharmaceuticals USA Inc (per FDA), Berkeley, NJ, 2023.
  3. US Food and Drug Administration (FDA): Drug Safety Communications: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks. US Food and Drug Administration (FDA). Silver Spring, MD. 2017.
  4. Product Information: DOLOPHINE(R) oral tablets, methadone HCl oral tablets. West-Ward Pharmaceuticals Corp (per FDA), Eatontown, NJ, 2019. DailyMed
Was this write-up helpful?

Other Serious Interactions of Methadone and Thiopropazate

Also serious with Methadone

Also serious with Thiopropazate

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Methadone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.